Silvana Galderisi
Silvana Galderisi
University of Campania Luigi Vanvitelli
Dirección de correo verificada de
Citado por
Citado por
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
RS Kahn, WW Fleischhacker, H Boter, M Davidson, Y Vergouwe, ...
The lancet 371 (9618), 1085-1097, 2008
How mental health care should change as a consequence of the COVID-19 pandemic
C Moreno, T Wykes, S Galderisi, M Nordentoft, N Crossley, N Jones, ...
The Lancet Psychiatry, 2020
Toward a new definition of mental health
S Galderisi, A Heinz, M Kastrup, J Beezhold, N Sartorius
World Psychiatry 14 (2), 231, 2015
Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST)
M Davidson, S Galderisi, M Weiser, N Werbeloff, WW Fleischhacker, ...
American Journal of Psychiatry 166 (6), 675-682, 2009
The status of spectral EEG abnormality as a diagnostic test for schizophrenia
NN Boutros, C Arfken, S Galderisi, J Warrick, G Pratt, W Iacono
Schizophrenia research 99 (1-3), 225-237, 2008
Evaluation of two new neuropsychological tests designed to minimize cultural bias in the assessment of HIV-1 seropositive persons: a WHO study
M Maj, L D'Elia, P Satz, R Janssen, M Zaudig, C Uchiyama, F Starace, ...
Archives of clinical Neuropsychology 8 (2), 123-135, 1993
The influence of illness‐related variables, personal resources and context‐related factors on real‐life functioning of people with schizophrenia
S Galderisi, A Rossi, P Rocca, A Bertolino, A Mucci, P Bucci, P Rucci, ...
World Psychiatry 13 (3), 275-287, 2014
The cortical generators of P3a and P3b: a LORETA study
U Volpe, A Mucci, P Bucci, E Merlotti, S Galderisi, M Maj
Brain research bulletin 73 (4-6), 220-230, 2007
EEG microstate duration and syntax in acute, medication-naive, first-episode schizophrenia: a multi-center study
D Lehmann, PL Faber, S Galderisi, WM Herrmann, T Kinoshita, ...
Psychiatry Research: Neuroimaging 138 (2), 141-156, 2005
Oxytocin receptor polymorphisms and adult attachment style in patients with depression
B Costa, S Pini, P Gabelloni, M Abelli, L Lari, A Cardini, M Muti, C Gesi, ...
Psychoneuroendocrinology 34 (10), 1506-1514, 2009
The current conceptualization of negative symptoms in schizophrenia
SR Marder, S Galderisi
World Psychiatry 16 (1), 14-24, 2017
Sources of cortical rhythms in adults during physiological aging: a multicentric EEG study
C Babiloni, G Binetti, A Cassarino, G Dal Forno, C Del Percio, F Ferreri, ...
Human brain mapping 27 (2), 162-172, 2006
Deconstructing vulnerability for psychosis: meta-analysis of environmental risk factors for psychosis in subjects at ultra high-risk
P Fusar-Poli, M Tantardini, S De Simone, V Ramella-Cravaro, D Oliver, ...
European Psychiatry 40, 65-75, 2017
Deficit schizophrenia: an update
B Kirkpatrick, S Galderisi
World Psychiatry 7 (3), 143, 2008
Historical, psychopathological, neurological, and neuropsychological aspects of deficit schizophrenia: a multicenter study
S Galderisi, M Maj, A Mucci, GB Cassano, G Invernizzi, A Rossi, A Vita, ...
American Journal of Psychiatry 159 (6), 983-990, 2002
Negative symptoms of schizophrenia: new developments and unanswered research questions
S Galderisi, A Mucci, RW Buchanan, C Arango
The Lancet Psychiatry 5 (8), 664-677, 2018
Categorical and dimensional approaches to negative symptoms of schizophrenia: focus on long-term stability and functional outcome
S Galderisi, P Bucci, A Mucci, B Kirkpatrick, S Pini, A Rossi, A Vita, M Maj
Schizophrenia research 147 (1), 157-162, 2013
Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial
S Galderisi, A Mucci, I Bitter, J Libiger, P Bucci, WW Fleischhacker, ...
European Neuropsychopharmacology 23 (3), 196-204, 2013
Schizophrenia—time to commit to policy change
WW Fleischhacker, C Arango, P Arteel, TRE Barnes, W Carpenter, ...
Schizophrenia bulletin 40 (Suppl_3), S165-S194, 2014
Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder on response and remission: an open randomized clinical trial (EUFEST)
H Boter, J Peuskens, J Libiger, WW Fleischhacker, M Davidson, ...
Schizophrenia research 115 (2-3), 97-103, 2009
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20